The International Planned Parenthood Federation Africa Region (IPPFAR) is appalled and deeply disturbed by the recent enactment of the anti-homosexuality act 2023 by President Museveni of Uganda. This regressive law represents a grave violation of human rights and sexual and reproductive rights, affecting not only the LGBTIQ+ community but all Ugandans. The draconian and abhorrent provisions of this law criminalize same-sex relationships and any promotion of homosexuality, subjecting individuals to severe penalties, including life imprisonment. Its implementation will have dire consequences, fostering a climate of homophobia, hatred, and hate crimes. The law instills fear not only among those directly targeted and their families but also among health workers providing essential Sexual and Reproductive Health (SRH) services in Uganda. IPPFAR is extremely concerned that this law blatantly violates numerous human rights, including the right to bodily autonomy. The right to life and dignity, freedom of expression and association, protection from discrimination, the right to a fair trial, protection against arbitrary arrest, and access to health services are all undermined, compromising the full realization of sexual and reproductive health and rights. "The IPPF Africa region vehemently condemns the anti-homosexuality act 2023, which targets the LGBTIQ+ community and their allies in Uganda. This law marks a sorrowful day for Uganda and its people," stated Marie-Evelyne Petrus-Barry, IPPF Africa Regional Director. "Targeting a community based solely on their shared characteristics is extremely dangerous and an undeniable violation of human rights. Instead, we should strive to empower all members of our society to be positive contributors, rather than driving them into hiding and marginalization," Petrus-Barry added. Since March 2023, IPPF has witnessed a surge in physical attacks against the LGBTIQ+ community, threats to the safety of civil society organizations, and an alarming increase in hate speech targeting LGBTIQ+ individuals and their allies. The anti-homosexuality act 2023 is discriminatory and flagrantly violates the fundamental freedoms enshrined in the Uganda constitution. By isolating itself from the international community, Uganda risks alienating potential collaborators and donors. Already, the U.S. Government has expressed intentions to suspend development funding to Uganda, including through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund and UNAIDs, potentially jeopardizing the progress in the fight against the HIV pandemic in Uganda. As the foremost provider of sexual and reproductive health (SRH) services in Africa, IPPFAR is immensely concerned that this law will deter individuals from seeking vital SRH services due to fear of being targeted. This will inevitably hinder access to life-saving services, including HIV/AIDS testing and treatment, provision of antiretroviral therapy, contraceptive services, and accurate SRH information. Moreover, the law obstructs healthcare professionals from fulfilling their duties and providing high-quality care in a safe and confidential environment. IPPFAR joins the chorus of condemnation against this harmful and regressive law. The safety, health, and dignity of all Ugandans must remain paramount. IPPF stands resolutely with the LGBTIQ+ community and their allies in Uganda and worldwide during this challenging time.   For media enquiries, please contact [email protected]   About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF, through its 118 Member Associations and seven partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people have the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.

The recent approval of Japan's first oral abortion pill is an important step towards achieving gender equality and ensuring that women exercise their right to self-determination over their bodies, including pregnancy and childbirth. IPPF believes that true gender equality requires empowering women to be fully informed and in control of their bodies, thereby expanding their choices and enabling them to determine their own futures. Dr Alvaro Bermejo, Director General of the International Planned Parenthood Federation (IPPF), underlined the importance of this landmark milestone during a visit to Japan in April. Public support through public comments for the approval shows that the social situation in Japan is changing, with increased awareness of women's lives and health, reproductive freedom and women's rights. In its guidelines, the World Health Organisation (WHO) included oral abortion pills in the Essential Medicines Core List, in line with the evidence accumulated in the past, and removed the requirement of direct supervision by health professionals for their use as these pills can be used outside healthcare facilities without compromising safety and efficacy and the abortion process can be managed using the drug without direct supervision of health professionals. IPPF urges Japan to follow these WHO guidelines, including abortion as part of women's health care, and allow women to take safe oral abortion pills at home. Guaranteeing women in its own country access to these essential medicines is also in line with Japan's strong commitment and global pledge to achieve Universal Health Coverage (UHC), ensuring that all women have access to medicines that save their health and lives, and that no one is left behind. IPPF looks forward to, and is committed to working with and supporting, Japan's future steps towards achieving a society that supports true gender equality, where women can exercise their right to self-determination over reproduction.

“We at IPPF are thinking of Sudanese colleagues and civilians trapped in a horrific situation right now in Khartoum and across Sudan with air strikes and gun battles around the city. Urgent and immediate steps must be taken to de-escalate the violence to avoid further civilian causalities including that of aid relief workers. Those on the frontline delivering much-needed care must be able to do so without becoming a target. Our local partner, the Sudan Family Planning Association, has already taken the ingenuity to devise a database of operational midwives and facilities for pregnant women who are due to deliver babies at any moment. We are closely monitoring the situation and are poised to respond," said IPPF Director-General Alvaro Bermejo. To learn more about the work Sudan Family Planning Association is doing with refugees fleeing Ethiopia, click here. 

The International Planned Parenthood Federation expresses its disappointment that the fifty-sixth session of the Commission on Population and Development (CPD), held from 10-14 April 2023 at UN headquarters in New York, did not result in a resolution on the theme of Population, Education and Sustainable Development.   The Chair’s draft resolution for consideration on 14th April was the result of many weeks of intergovernmental discussions and represented a compromise to address the positions of all delegations. It was a balanced text based on previously agreed language and included critical elements related to this year’s priority theme, including ensuring a comprehensive response to the learning crises the world is facing today. Key issues including the need for gender-responsive policy development, a focus on marginalized communities, youth and adolescents, sexual and reproductive health and reproductive rights were consensually included in the draft resolution, demonstrating global consensus on these issues. However, consensus on the document was unfortunately broken by a small minority of Member States who were unable to accept language pertaining to comprehensive education on human sexuality, which was language adopted at this very Commission in 2014, and which comes from the 1994 ICPD Programme of Action itself. It is disappointing that these few Member States found it more important to block agreed language than to adopt meaningful advancements in the area of education. The ramifications of the failure to adopt this resolution will have an impact on billions of young people, adolescents and girls worldwide who have experienced the largest disruption of education systems in history, where more than 90 % of the world’s children have had their education interrupted by COVID-19 and 263 million children and young people are still out of school (1 in 5). IPPF is, however, encouraged that the negotiations on this resolution, which took place over several weeks, demonstrated the on-going commitment of Member States to the the ICPD Programme of Action (PoA), the key actions for its further implementation, the declaration on the occasion of the twenty-fifth anniversary of the International Conference on Population and Development, and resolutions and work of the Commission on Population and Development. We also welcome the plenary program of the 56th session of the CPD, which featured strong data on comprehensive sexuality education from UN agencies as evidence of its beneficial impact on children, adolescents and  young people. In addition (or equally important), the experience of national programs and the passionate voices of young people reaffirmed that comprehensive sexuality education is an essential tool to empower young people and adolescents to make informed choices about their bodies, lives and futures.  With a view towards the 30th anniversary of the ICPD PoA in 2024, we appreciate the commitment of Member States to continue working to deliver on the Programme of Action of the International Conference on Population and Development (ICPD) and look forward to engaging in the national, regional, and global processes of ICPD+30, culminating in next year’s 57th session of the Commission on Population and Development.

Texas judge, Matthew Kacsmaryk, has suspended the U.S. Food and Drug Administration's (FDA) approval of the abortion pill Mifepristone in a horror move for abortion access across the United States. The decision will result in a nationwide ban on Mifepristone in seven days, with the FDA given one week to appeal the ruling. While the ban also affected access in states that have secured abortion post-Roe v Wade, a conflicting ruling from Judge Thomas O. Rice from a federal court in Washington state ordered the FDA to maintain access to Mifepristone in 17 democratic states and Colombia District – effectively putting access to the pill into limbo. Mifepristone, which has been FDA-approved for more than 22 years and has a safety record of over 99%[i], is taken alongside the drug Misoprostol during medical abortion procedures. Since then, it has been used by over 5 million[ii] Americans and was used in more than half of abortions nationwide last year. While Misoprostol can be used alone in medical abortion, people should have access to the full spectrum of abortion care options. Mifepristone is also used in the medical management of miscarriage and second and third-trimester pregnancies when the fetus has died before birth. While the ruling does not prohibit the FDA from making a new authorization for Mifepristone, this will likely take many months. Severe disruption to abortion care services, healthcare services and supply chain issues are expected as healthcare providers and pharmacies grapple with legality, stock, retraining and reeducation. Beth Schlachter, Director of Global Advocacy for the International Planned Parenthood Federation, said: "For 22 years, Mifepristone has been safely used in medical abortion care across the U.S., allowing healthcare providers to deliver safe, practical and discreet care to people who have chosen to end their pregnancies, regardless of their economic status or ability to travel. "In one fell swoop, anti-abortion extremists have once again stripped people of their rights in another blow to liberty. This horror ruling based on junk science, wilful distortion of fact and extreme political agendas will profoundly affect the lives of millions of people already struggling to access the care they need, especially in states where abortion is already banned." Anti-abortion extremists deliberately filed the case against the approval of Mifepristone in the Amarillo division of the Northern District of Texas — a single-judge division where cases are automatically assigned to Judge Matthew Kacsmaryk, a conservative judge appointed by former President Trump. The group claim that: "the statutory basis on which the FDA's approval of Mifepristone was issued 22 years ago is invalid" - an assertion both the Government Accountability Office and FDA have previously investigated and put to rest "an 1873 vice law that made it illegal to send "obscene, lewd or lascivious" material through the mail applies to abortion pills" - federal courts have consistently ruled it doesn't apply to lawful abortions "the drug's original approval wasn't supported by evidence of safety and efficacy" — a claim that medical and policy experts have continuously discredited Beth Schlachter, added: "The implementation of a national ban on Mifepristone via a state court debunks one of the principal anti-abortion arguments in the Roe v Wade case  - that the ruling curtailed state freedom and that abortion rights should be defined on a state-by-state basis. "This weaponization of federal courts by anti-abortion extremists proves just how dangerous the overturning of Roe v Wade is for everyday Americans, whose access to healthcare now lies in the hands of fanatical religious extremists determined to disrupt, harass and deceive until they end access to abortion care and long-held sexual and reproductive rights for good." The International Planned Parenthood Federation's local partner, the Planned Parenthood Federation of America, will continue to provide abortion care where safe and legal to do so. Those seeking medical abortion can also access care via AidAccess and WomenonWeb. At least two abortion networks, Trust Women and Whole Womans Health, have also announced that they will not immediately stop prescribing Mifepristone and will await a directive from the FDA – a move known as a conscientious provision which refers to providers who continue to provide care despite the legal parameters.   Alongside its partner and other reproductive health organizations, IPPF will keep fighting for access to abortion care, freedom from stigma and freedom from criminalization until everyone, everywhere, is free to make choices about their sexuality and well-being. [i] https://www.plannedparenthood.org/uploads/filer_public/42/8a/428ab2ad-3798-4e3d-8a9f-213203f0af65/191011-the-facts-on-mifepristone-d01.pdf [ii] Ibid For media enquiries, please contact Karmen Ivey at [email protected] or [email protected]   About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF, through its 118 Member Associations and seven partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people have the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.  

The Director General of the International Planned Parenthood Federation (IPPF), Dr Alvaro Bermejo, is in Australia this week for high level meetings with Australian Government Ministers and the Australian Department of Foreign Affairs and Trade (DFAT). He is joined by Ms Tomoka Fukuda, Regional Director of IPPF’s East and Southeast Asia and Oceania Region (ESEAOR) and Ms Phoebe Ryan, IPPF’s Chief of the Australia and New Zealand Office. In Australia, Dr Bermejo has been privileged to meet with Australia’s Minister for International Development and the Pacific, the Hon Pat Conroy. Together, they discussed how Australia can play a leadership role in advancing sexual and reproductive health and rights through Australia’s international development cooperation. Last week, Dr Bermejo and Ms Fukuda visited IPPF’s Member Association in Solomon Islands, the Solomon Islands Planned Parenthood Association (SIPPA). In Solomon Islands, they witnessed SIPPA’s life-saving and critical work delivering sexual and reproductive healthcare on the ground, including mobile outreach in remote communities of Malaita Province. Australia has been a long-standing and critical partner to IPPF, supporting programming to reach women, girls, and marginalized groups across the development–humanitarian continuum around the world, with a particular focus on the Asia Pacific. In December 2022, IPPF and DFAT signed a new four-year global funding agreement for 2023 to 2026, part of which includes dedicated support to programming across the Pacific. AUD 19 million is dedicated as global funding towards the delivery of IPPF’s Strategy 2028, along with a further AUD 5.7 million to support the delivery of IPPF’s Pacific Niu Vaka Strategy, Phase 2. This generous investment will enable IPPF to reach an anticipated 1.8 million people in the Pacific over the next six years with 4.2 million essential sexual and reproductive services. IPPF is proud to stand alongside our Pacific MAs as they continue to advocate for the health and rights of those most underserved and excluded, reaching communities with essential information and high quality, person-centred sexual and reproductive health care.     In 2021, IPPF reached over 72 million people around the world with more than 155 million sexual and reproductive health services and contributed to 121 policy and legislative changes in defence of SRHR. IPPF is grateful for Australia’s ongoing support in enabling this impact. IPPF’s Director General, Alvaro Bermejo shared: “IPPF are delighted to be working with the Australian Government to continue improving the sexual and reproductive health and rights (SRHR) of women and girls across the globe. We are grateful to them for helping us deliver more services and support at a time when inequalities are deepening, the opposition is growing, and humanitarian crises continue to place the lives of millions, particularly women and girls, at risk. As we look to build the future with our new strategy, continued support from global partners is crucial to achieving a world where everyone has access to sexual and reproductive healthcare. We hope DFAT’s strong global commitment will inspire other global leaders to take action.” For media enquiries, please contact Karmen Ivey on [email protected] or Phoebe Ryan on [email protected]    About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people are provided with the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.